Name of measure | Number of studies using measure | Components of pain related to pelvic mesh implants covered by each measure | |||||
---|---|---|---|---|---|---|---|
Timing (Onset/duration/ frequency of pain) | Intensity | Impact/interference* | Location** | Phenomenological qualities | Patient expectations or beliefs | ||
Analgesia amount/length of time used | 25 | x | x | Â | Â | Â | Â |
Anatomical diagram for patient completion (non-standardised) | 2 | Â | Â | Â | x | Â | Â |
Brief pain inventory | 1 | Â | x | 1, 2, 3, 4 | x | Â | Â |
Bristol Female lower urinary tract symptoms questionnaire | 1 | x | Â | 2, 4 | x | x | Â |
Clavien-Dindo classification | 17 | Â | x | Â | Â | Â | Â |
Diary of symptoms | 5 | x | x | Â | x | Â | Â |
Electronic personal assessment questionnaire—pelvic floor | 2 | x |  | 1, 2, 3, 4 | x | x |  |
EQ-5D-5L | 8 | Â | x | 1, 3, 4 | Â | Â | Â |
Female genitourinary pain index | 1 | x | x | 1, 2, 3, 4 | x | x | Â |
Female sexual function index | 23 | x | x | 2 | Â | x | Â |
International consultation on incontinence questionnaire vaginal symptoms | 28 | x | Â | 2, 4 | x | x | Â |
International urogynaecology association (IUGA) complication grades | 19 | x | Â | 1, 2 | x | Â | Â |
King’s health questionnaire | 12 |  | x | 1, 2, 3, 4 | x |  |  |
McGill pain questionnaire | 2 | Â | x | 1, 2 | Â | x | Â |
Novel measures/measures with no psychometric information*** | 28 | N/A | N/A | N/A | N/A | N/A | N/A |
Numeric rating scale for pain | 15 | Â | x | Â | Â | Â | Â |
Pain catastrophizing scale | 1 | Â | x | 3 | Â | Â | x |
Patient global impression of improvement | 56 | x | x | 1, 2, 3, 4 | Â | Â | Â |
Pelvic Floor distress inventory (PFDI; or the short form PFDI-20) | 68 | x | Â | 1 | x | x | Â |
Colorectal-anal distress inventory as standalone subscale | 2 | x | Â | 1 | Â | Â | Â |
Urinary distress inventory as standalone subscale | 38 | x | Â | 1 | x | Â | Â |
Pelvic floor impact questionnaire (PFIQ; or the short form PFIQ-7) | 44 | x | Â | 1, 3, 4 | x | Â | Â |
Pelvic organ prolapse–urinary incontinence sexual Function questionnaire (PISQ; or the short form PISQ-12, or revised PISQ-IR) | 62 | x |  | 2 |  | x |  |
Pelvic organ prolapse symptom score | 2 | x | Â | 1, 4 | x | x | Â |
Pelvic pain and urgency/frequency patient symptom scale | 1 | x | x | 2, 4 | x | Â | Â |
Physical exam and/or oral report as an exclusive measure*** | 70 | N/A | N/A | N/A | N/A | N/A | N/A |
Physical exam and/or oral report in addition to self-report measures*** | 100 | N/A | N/A | N/A | N/A | N/A | N/A |
Prolapse quality of life questionnaire | 10 | x | Â | 1, 2, 3, 4 | Â | x | Â |
Short-form health survey (SF-36/SF-12) | 13 | x | x | 1, 3, 4 | Â | Â | Â |
Visual analogue scale for pain | 70 | Â | x | Â | Â | Â | Â |
Wong-Baker FACES scale | 3 | Â | x | Â | Â | Â | Â |